These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 19035297)

  • 21. Methylation status of T-lymphoma invasion and metastasis 1 promoter and its overexpression in colorectal cancer.
    Jin H; Li T; Ding Y; Deng Y; Zhang W; Yang H; Zhou J; Liu C; Lin J; Ding Y
    Hum Pathol; 2011 Apr; 42(4):541-51. PubMed ID: 21237486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Demethylation of the CDH3 gene is frequently detected in advanced colorectal cancer.
    Hibi K; Goto T; Mizukami H; Kitamura YH; Sakuraba K; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
    Anticancer Res; 2009 Jun; 29(6):2215-7. PubMed ID: 19528483
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Demethylation of the CD133 gene is frequently detected in advanced colorectal cancer.
    Hibi K; Sakata M; Kitamura YH; Sakuraba K; Shirahata A; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
    Anticancer Res; 2009 Jun; 29(6):2235-7. PubMed ID: 19528487
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aberrant methylation of the CHFR gene is frequently detected in non-invasive colorectal cancer.
    Morioka Y; Hibi K; Sakai M; Koike M; Fujiwara M; Kodera Y; Ito K; Nakao A
    Anticancer Res; 2006; 26(6B):4267-70. PubMed ID: 17201143
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PGP9.5 promoter methylation is an independent prognostic factor for esophageal squamous cell carcinoma.
    Mandelker DL; Yamashita K; Tokumaru Y; Mimori K; Howard DL; Tanaka Y; Carvalho AL; Jiang WW; Park HL; Kim MS; Osada M; Mori M; Sidransky D
    Cancer Res; 2005 Jun; 65(11):4963-8. PubMed ID: 15930319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CpG methylation of ubiquitin carboxyl-terminal hydrolase 1 (UCHL1) and P53 mutation pattern in sporadic colorectal cancer.
    Abdelmaksoud-Dammak R; Saadallah-Kallel A; Miladi-Abdennadher I; Ayedi L; Khabir A; Sallemi-Boudawara T; Frikha M; Daoud J; Mokdad-Gargouri R
    Tumour Biol; 2016 Feb; 37(2):1707-14. PubMed ID: 26314856
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of PGP9.5 expression in cancer-associated fibroblasts for prognosis of colorectal carcinoma.
    Akishima-Fukasawa Y; Ino Y; Nakanishi Y; Miura A; Moriya Y; Kondo T; Kanai Y; Hirohashi S
    Am J Clin Pathol; 2010 Jul; 134(1):71-9. PubMed ID: 20551269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methylation status in the promoter region of the human PGP9.5 gene in cancer and normal tissues.
    Bittencourt Rosas SL; Caballero OL; Dong SM; da Costa Carvalho Mda G; Sidransky D; Jen J
    Cancer Lett; 2001 Sep; 170(1):73-9. PubMed ID: 11448537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of methylated p15 and p16 genes on clinicopathological features in colorectal cancer.
    Ishiguro A; Takahata T; Saito M; Yoshiya G; Tamura Y; Sasaki M; Munakata A
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1334-9. PubMed ID: 16872319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymph node metastasis is infrequent in patients with highly-methylated colorectal cancer.
    Hibi K; Nakao A
    Anticancer Res; 2006; 26(1A):55-8. PubMed ID: 16475679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGF-β1 induces PGP9.5 expression in CAFs to promote the growth of colorectal cancer cells.
    Wen W; Liu G; Jin K; Hu X
    Oncol Rep; 2017 Jan; 37(1):115-122. PubMed ID: 27840994
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of PGP9.5 as a tumor suppressor gene in human cancer.
    Tokumaru Y; Yamashita K; Kim MS; Park HL; Osada M; Mori M; Sidransky D
    Int J Cancer; 2008 Aug; 123(4):753-9. PubMed ID: 18512240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of TFPI2 methylation in the serum of gastric cancer patients.
    Hibi K; Goto T; Shirahata A; Saito M; Kigawa G; Nemoto H; Sanada Y
    Anticancer Res; 2011 Nov; 31(11):3835-8. PubMed ID: 22110206
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of the protein gene product 9.5, PGP9.5, is correlated with T-status in non-small cell lung cancer.
    Sasaki H; Yukiue H; Moriyama S; Kobayashi Y; Nakashima Y; Kaji M; Fukai I; Kiriyama M; Yamakawa Y; Fujii Y
    Jpn J Clin Oncol; 2001 Nov; 31(11):532-5. PubMed ID: 11773260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. RUNX3 promoter region is specifically methylated in poorly-differentiated colorectal cancer.
    Imamura Y; Hibi K; Koike M; Fujiwara M; Kodera Y; Ito K; Nakao A
    Anticancer Res; 2005; 25(4):2627-30. PubMed ID: 16080503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hypomethylation of 5'CpG island of insulin-like growth factor binding protein-related protein 1 is associated with its overexpression in colorectal cancer].
    Lin J; Zhu YM; Shao LN; Huang Q; Lai MD
    Zhonghua Bing Li Xue Za Zhi; 2008 Aug; 37(8):512-6. PubMed ID: 19094461
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Methylation of the MGMT gene is frequently detected in advanced gastric carcinoma.
    Hibi K; Sakata M; Yokomizo K; Kitamura YH; Sakuraba K; Shirahata A; Goto T; Mizukami H; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
    Anticancer Res; 2009 Dec; 29(12):5053-5. PubMed ID: 20044616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PGP9.5 methylation in diffuse-type gastric cancer.
    Yamashita K; Park HL; Kim MS; Osada M; Tokumaru Y; Inoue H; Mori M; Sidransky D
    Cancer Res; 2006 Apr; 66(7):3921-7. PubMed ID: 16585221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered regulation of DNA ligase IV activity by aberrant promoter DNA methylation and gene amplification in colorectal cancer.
    Kuhmann C; Li C; Kloor M; Salou M; Weigel C; Schmidt CR; Ng LW; Tsui WW; Leung SY; Yuen ST; Becker N; Weichenhan D; Plass C; Schmezer P; Chan TL; Popanda O
    Hum Mol Genet; 2014 Apr; 23(8):2043-54. PubMed ID: 24282031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
    Bae JM; Rhee YY; Kim KJ; Wen X; Song YS; Cho NY; Kim JH; Kang GH
    Hum Pathol; 2016 Jan; 47(1):85-94. PubMed ID: 26520418
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.